Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer

被引:171
|
作者
Timmerman, Robert D. [1 ]
Hu, Chen [2 ,3 ]
Michalski, Jeff M. [4 ]
Bradley, Jeffrey C. [4 ]
Galvin, James [5 ]
Johnstone, David W. [6 ]
Choy, Hak [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, 5801 Forest Pk Rd, Dallas, TX 75390 USA
[2] NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA
[3] Johns Hopkins Univ, Sch Med, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[4] Washington Univ St Louis, Dept Radiat Oncol, St Louis, MO USA
[5] Imaging & Radiat Oncol Core, Philadelphia, PA USA
[6] Med Coll Wisconsin, Div Cardiothorac Surg, Milwaukee, WI 53226 USA
关键词
D O I
10.1001/jamaoncol.2018.1258
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1287 / 1288
页数:2
相关论文
共 50 条
  • [21] Initial report of a prospective phase II trial of stereotactic body radiation therapy for patients with medically inoperable stage I non-small cell lung cancer
    Timmerman, R
    McGarry, R
    Papiez, L
    Yiannoutsos, C
    Whitford, T
    DeLuca, J
    Tudor, K
    Williams, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S99 - S99
  • [22] Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer
    Videtic, Gregory M. M.
    Stephans, Kevin L.
    Woody, Neil M.
    Pennell, Nathan A.
    Shapiro, Marc
    Reddy, Chandana A.
    Djemil, Toufik
    PRACTICAL RADIATION ONCOLOGY, 2013, 3 (04) : 301 - 306
  • [23] Stereotactic Body Radiation Therapy for Patients with Early-Stage Non-small Cell Lung Cancer Inoperable
    Pham, L. V.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S518 - S518
  • [24] Collaborating to assess the role of stereotactic body radiation therapy in medically operable stage I non-small cell lung cancer
    Cornwell, Lorraine D.
    Moghanaki, Drew
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3311 - S3313
  • [25] Long-term Dependency in Older Adults After Surgery or Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
    Hirpara, Dhruvin
    Kidane, Biniam V.
    Louie, Alexander
    Zuk, Victoria
    Darling, Gail
    Rousseau, Mathieu
    Chesney, Tyler
    Coburn, Natalie
    Hallet, Julie
    ANNALS OF SURGERY, 2023, 278 (02) : E368 - E376
  • [26] A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer The Cleveland Clinic Experience
    Stephans, Kevin L.
    Djemil, Toufik
    Reddy, Chandana A.
    Gajdos, Stephen M.
    Kolar, Matthew
    Mason, David
    Murthy, Sudish
    Rice, Thomas W.
    Mazzone, Peter
    Machuzak, Michael
    Mekhail, Tarek
    Videtic, Gregory M. M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (08) : 976 - 982
  • [27] Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
    Chi, Alexander
    Nguyen, Nam P.
    CANCERS, 2022, 14 (13)
  • [28] The Impact of Tumor Size on Outcomes After Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
    Allibhai, Zishan
    Taremi, Mojgan
    Bezjak, Andrea
    Brade, Anthony
    Hope, Andrew J.
    Sun, Alexander
    Cho, B. C. John
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05): : 1064 - 1070
  • [29] Long-term Follow-up and Patterns of Failure for Patients with Medically Inoperable Stage I Non-small Cell Lung Cancer (NSCLC) treated with Stereotactic Body Radiotherapy (SBRT)
    Urbanic, J. J.
    Soike, M.
    Hampton, C. J.
    Lucas, J.
    Hinson, W.
    Kearns, W.
    Blackstock, A. W.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S288 - S288
  • [30] A Phase II Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-risk Medically Inoperable Early-stage Non-small Cell Lung Cancer
    Hurmuz, Pervin
    Ozyigit, Gokhan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (03): : 744 - 745